TrialHepatology international2022

Safety and efficacy of Thymosin α1 in the treatment of hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trial.

Jun-Feng Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.